Aktienanalyse zu Natural Alternatives International Inc (NAII)NAIINatural Alternatives International Inc

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer's preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Natural Alternatives International Inc is not a good buy right now due to ongoing financial losses and declining performance metrics. The current price is $2.16, and the company reported a net loss of $4.3 million for Q3 2026, translating to a diluted loss of $0.72 per share. Although there was a 23% increase in net sales compared to the previous year, the overall financial health remains concerning, particularly with a forward P/E of 13.61 indicating potential overvaluation given the losses.